Patent · US Active

ABT-263 crystalline forms

US8362014B2 · kind B2 · utility

1Cited by

1References

2Claims

0Family size

Assignee

Abb Vie Inc. · US

Inventors

Geoff G. Zhang · Vernon Hills, US
Paul J. Brackemeyer · Mount Prospect, US
Nathaniel Catron · Vernon Hills, US
Thomas B. Borchardt · Kenosha, US

Key dates

Filing date	Sep 15, 2010
Grant date	Jan 29, 2013
Priority date	—
Expiry date	Sep 15, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

ABT-263 free base and crystalline forms thereof are suitable active pharmaceutical ingredients for pharmaceutical compositions useful in treatment of a disease characterized by overexpression of one or more anti-apoptotic Bcl-2 family proteins, for example cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.